| The global ascendency of OXA-48-type carbapenemases JDD Pitout, G Peirano, MM Kock, KA Strydom, Y Matsumura Clinical microbiology reviews 33 (1), 10.1128/cmr. 00102-19, 2019 | 379 | 2019 |
| Global Escherichia coli sequence type 131 clade with blaCTX-M-27 gene Y Matsumura, JDD Pitout, R Gomi, T Matsuda, T Noguchi, M Yamamoto, ... Emerging infectious diseases 22 (11), 1900, 2016 | 181 | 2016 |
| CTX-M-27- and CTX-M-14-producing, ciprofloxacin-resistant Escherichia coli of the H30 subclonal group within ST131 drive a Japanese regional ESBL epidemic Y Matsumura, JR Johnson, M Yamamoto, M Nagao, M Tanaka, ... Journal of Antimicrobial Chemotherapy 70 (6), 1639-1649, 2015 | 138 | 2015 |
| Genomic epidemiology of global carbapenemase-producing Enterobacter spp., 2008–2014 G Peirano, Y Matsumura, MD Adams, P Bradford, M Motyl, L Chen, ... Emerging infectious diseases 24 (6), 1010, 2018 | 133 | 2018 |
| Serotypes, antimicrobial susceptibility, and molecular epidemiology of invasive and non-invasive Streptococcus pneumoniae isolates in paediatric patients after the introduction … S Nakano, T Fujisawa, Y Ito, B Chang, S Suga, T Noguchi, M Yamamoto, ... Vaccine 34 (1), 67-76, 2016 | 122 | 2016 |
| Emergence and spread of B2-ST131-O25b, B2-ST131-O16 and D-ST405 clonal groups among extended-spectrum-β-lactamase-producing Escherichia coli in Japan Y Matsumura, M Yamamoto, M Nagao, G Hotta, A Matsushima, Y Ito, ... Journal of antimicrobial chemotherapy 67 (11), 2612-2620, 2012 | 120 | 2012 |
| Clinical characteristics of Pneumocystis pneumonia in non-HIV patients and prognostic factors including microbiological genotypes Y Matsumura, Y Shindo, Y Iinuma, M Yamamoto, M Shirano, ... BMC infectious diseases 11, 1-9, 2011 | 116 | 2011 |
| Quantitative real-time PCR and the (1→ 3)-β-D-glucan assay for differentiation between Pneumocystis jirovecii pneumonia and colonization Y Matsumura, Y Ito, Y Iinuma, K Yasuma, M Yamamoto, A Matsushima, ... Clinical microbiology and infection 18 (6), 591-597, 2012 | 107 | 2012 |
| Close cooperation between infectious disease physicians and attending physicians can result in better management and outcome for patients with Staphylococcus aureus bacteraemia M Nagao, Y Iinuma, T Saito, Y Matsumura, M Shirano, A Matsushima, ... Clinical microbiology and infection 16 (12), 1783-1788, 2010 | 106 | 2010 |
| Multicenter retrospective study of cefmetazole and flomoxef for treatment of extended-spectrum-β-lactamase-producing Escherichia coli bacteremia Y Matsumura, M Yamamoto, M Nagao, T Komori, N Fujita, A Hayashi, ... Antimicrobial agents and chemotherapy 59 (9), 5107-5113, 2015 | 105 | 2015 |
| Rapid identification of different Escherichia coli sequence type 131 clades Y Matsumura, JDD Pitout, G Peirano, R DeVinney, T Noguchi, ... Antimicrobial Agents and Chemotherapy 61 (8), 10.1128/aac. 00179-17, 2017 | 101 | 2017 |
| Accidental exposures to blood and body fluid in the operation room and the issue of underreporting M Nagao, Y Iinuma, J Igawa, Y Matsumura, M Shirano, A Matsushima, ... American Journal of Infection Control 37 (7), 541-544, 2009 | 97 | 2009 |
| Fluoroquinolones versus trimethoprim-sulfamethoxazole for the treatment of Stenotrophomonas maltophilia infections: a systematic review and meta-analysis JH Ko, CI Kang, P Cornejo-Juárez, KM Yeh, CH Wang, SY Cho, ... Clinical Microbiology and Infection 25 (5), 546-554, 2019 | 93 | 2019 |
| Association of fluoroquinolone resistance, virulence genes, and IncF plasmids with extended-spectrum-β-lactamase-producing Escherichia coli sequence type 131 (ST131) and ST405 … Y Matsumura, M Yamamoto, M Nagao, Y Ito, S Takakura, S Ichiyama Antimicrobial agents and chemotherapy 57 (10), 4736-4742, 2013 | 90 | 2013 |
| Global molecular epidemiology of IMP-producing Enterobacteriaceae Y Matsumura, G Peirano, MR Motyl, MD Adams, L Chen, B Kreiswirth, ... Antimicrobial agents and chemotherapy 61 (4), 10.1128/aac. 02729-16, 2017 | 84 | 2017 |
| Whole-genome analysis of antimicrobial-resistant and extraintestinal pathogenic Escherichia coli in river water R Gomi, T Matsuda, Y Matsumura, M Yamamoto, M Tanaka, S Ichiyama, ... Applied and Environmental Microbiology 83 (5), e02703-16, 2017 | 79 | 2017 |
| Detection of extended-spectrum-β-lactamase-producing Escherichia coli ST131 and ST405 clonal groups by matrix-assisted laser desorption ionization–time of flight mass spectrometry Y Matsumura, M Yamamoto, M Nagao, M Tanaka, K Machida, Y Ito, ... Journal of clinical microbiology 52 (4), 1034-1040, 2014 | 74 | 2014 |
| Genomic epidemiology of global VIM-producing Enterobacteriaceae Y Matsumura, G Peirano, R Devinney, PA Bradford, MR Motyl, MD Adams, ... Journal of Antimicrobial Chemotherapy 72 (8), 2249-2258, 2017 | 70 | 2017 |
| Risk factors and outcomes of Stenotrophomonas maltophilia bacteraemia: a comparison with bacteraemia caused by Pseudomonas aeruginosa and Acinetobacter species G Hotta, Y Matsumura, K Kato, S Nakano, T Yunoki, M Yamamoto, ... PLoS One 9 (11), e112208, 2014 | 70 | 2014 |
| Characteristics of carbapenemase-producing Enterobacteriaceae in wastewater revealed by genomic analysis R Gomi, T Matsuda, M Yamamoto, PH Chou, M Tanaka, S Ichiyama, ... Antimicrobial agents and chemotherapy 62 (5), 10.1128/aac. 02501-17, 2018 | 66 | 2018 |
Gisele PeiranoResearch associate在 albertaprecisionlabs.ca 的电子邮件经过验证
